AU3138800A - Elisa kit for the determination of metabolic phenotypes - Google Patents

Elisa kit for the determination of metabolic phenotypes

Info

Publication number
AU3138800A
AU3138800A AU31388/00A AU3138800A AU3138800A AU 3138800 A AU3138800 A AU 3138800A AU 31388/00 A AU31388/00 A AU 31388/00A AU 3138800 A AU3138800 A AU 3138800A AU 3138800 A AU3138800 A AU 3138800A
Authority
AU
Australia
Prior art keywords
determination
elisa kit
metabolic phenotypes
phenotypes
metabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31388/00A
Inventor
Brian Leyland-Jones
Pierre Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRIAN LEYLAND JONES
Original Assignee
BRIAN LEYLAND JONES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRIAN LEYLAND JONES filed Critical BRIAN LEYLAND JONES
Publication of AU3138800A publication Critical patent/AU3138800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU31388/00A 1999-03-15 2000-03-09 Elisa kit for the determination of metabolic phenotypes Abandoned AU3138800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12448899P 1999-03-15 1999-03-15
US60124488 1999-03-15
PCT/CA2000/000246 WO2000055624A2 (en) 1999-03-15 2000-03-09 Elisa kit for the determination of metabolic phenotypes

Publications (1)

Publication Number Publication Date
AU3138800A true AU3138800A (en) 2000-10-04

Family

ID=22415174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31388/00A Abandoned AU3138800A (en) 1999-03-15 2000-03-09 Elisa kit for the determination of metabolic phenotypes

Country Status (5)

Country Link
EP (1) EP1163518A2 (en)
JP (1) JP2002539450A (en)
AU (1) AU3138800A (en)
CA (1) CA2366085A1 (en)
WO (1) WO2000055624A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002231529A1 (en) * 2001-02-09 2002-08-28 Mcgill University Multiple determinants for metabolic phenotypes
US20030138377A1 (en) * 2001-02-28 2003-07-24 Brian Leyland-Jones Use of metabolic phenotyping in individualized treatment with amonafide
US20030068273A1 (en) * 2001-03-14 2003-04-10 Mcgill University Individualization of therapy with immunosuppressants
WO2002073196A2 (en) * 2001-03-14 2002-09-19 Mcgill University Individualization of therapy with antipsychotics
WO2002073197A2 (en) * 2001-03-14 2002-09-19 Mcgill University Individualization of therapy with antidepressants
US20030175210A1 (en) * 2001-03-14 2003-09-18 Mcgill University Individualization of therapy with anxiolitics
WO2002095402A2 (en) * 2001-04-18 2002-11-28 Mcgill University Individualization of therapy with hyperlipidemia agents
WO2002084288A2 (en) * 2001-04-18 2002-10-24 Mcgill University Individualization of therapy with antiarrhythmics
WO2002086508A2 (en) * 2001-04-23 2002-10-31 Mcgill University Elisa kit for the determination of cyp2c19 metabolic phenotypes and uses thereof
US20030049204A1 (en) * 2001-04-24 2003-03-13 Mcgill University Individualization of therapy with gastroesophageal reflux disease agents
EP1386156A2 (en) * 2001-04-30 2004-02-04 McGILL UNIVERSITY Individualization of therapy with antineoplastic agents
AU2002302223A1 (en) * 2001-05-07 2002-11-18 Mcgill University Individualization of therapy with analgesics
WO2002093162A2 (en) * 2001-05-17 2002-11-21 Mcgill University Individualization of therapy with antibiotic agents
US20030138375A1 (en) * 2001-06-06 2003-07-24 Mcgill University Individualization of therapy with Alzheimer's disease agents
WO2003008637A2 (en) * 2001-07-17 2003-01-30 Xanthus Life Sciences, Inc. Use of genotyping in the individualization of therapy
US20030195350A1 (en) * 2001-11-28 2003-10-16 Xanthus Life Sciences, Inc Individualization of therapy with antiviral agents
WO2003052123A1 (en) * 2001-12-19 2003-06-26 Xanthus Life Sciences, Inc. Individualization of therapy with antihistamines
WO2003052425A2 (en) * 2001-12-19 2003-06-26 Xanthus Life Sciences, Inc. Elisa kit for cyp 2c9 metabolic phenotypes
AU2002333079A1 (en) * 2002-02-08 2003-09-02 Mcgill University Individualization of therapy with anxiolitics
WO2003089928A1 (en) * 2002-04-19 2003-10-30 Pfizer Products Inc. Test for measurement of therapeutic drug levels
WO2004003550A2 (en) * 2002-06-28 2004-01-08 Xanthus Life Sciences, Inc. Individualization of therapy with anticoagulants
US20040204862A1 (en) 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
CA2582022C (en) * 2004-09-30 2021-05-18 Vanda Pharmaceuticals, Inc. Methods for the administration of iloperidone
CN102796102B (en) * 2012-06-13 2015-09-16 广州万孚生物技术股份有限公司 Caffeine haptens, conjugate and application, caffeine detection or measuring method
CN102925567B (en) * 2012-10-23 2013-12-11 山东省皮肤病性病防治研究所 Use of HLA-B*1301 alleles
CN111228518A (en) * 2020-02-19 2020-06-05 无锡艾德美特生物科技有限公司 Probe substrate for in vivo detection of CYP1A activity and application thereof
CN114605322B (en) * 2022-02-25 2023-06-27 华南农业大学 Dextromethorphan hapten, artificial antigen and antibody as well as preparation methods and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7452094A (en) * 1993-08-06 1995-02-28 Board Of Regents, The University Of Texas System Use of monoclonal antibodies for determining sensitivity to acetylizable drugs
US5478723A (en) * 1993-09-27 1995-12-26 Parkinson; Andrew Method and apparatus for determining the role of cytochrome P450 and related enzymes in the metabolism of drugs and other chemicals
CA2167330A1 (en) * 1996-01-31 1997-08-01 Xanthus Life Sciences, Inc. Elisa kit for the rapid determination of n-acetyltransferase (nat2) phenotypes

Also Published As

Publication number Publication date
WO2000055624A3 (en) 2001-02-01
CA2366085A1 (en) 2000-09-21
WO2000055624A2 (en) 2000-09-21
JP2002539450A (en) 2002-11-19
EP1163518A2 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
AU3138800A (en) Elisa kit for the determination of metabolic phenotypes
AUPQ496500A0 (en) Kit
AU2270101A (en) Pharmaceutical kit
AU2001268163A1 (en) Haplotypes of the ube3a gene
AU6459200A (en) Determining properties of magnetic elements
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU4000700A (en) Flag golf
AU2002257401A1 (en) Elisa kit for the determination of cyp2c19 metabolic phenotypes and uses thereof
AU2001282360A1 (en) Kit of adhesion-release agents
AU2002228618A1 (en) Haplotypes of the lipe gene
AU2001284736A1 (en) Haplotypes of the pla2g1b gene
AU2001290603A1 (en) Haplotypes of the or11a1 gene
AU2710499A (en) Timepiece
AU6719300A (en) Building kit
AU2002228727A1 (en) Haplotypes of the chrm4 gene
AU5921900A (en) Financing of tenant improvements
AU2001288868A1 (en) Haplotypes of the gpr68 gene
AU2001296261A1 (en) Haplotypes of the gpr7 gene
AU2002245073A1 (en) Haplotypes of the f2rli gene
AU2001249650A1 (en) Haplotypes of the chrnb3 gene
AU2001292815A1 (en) Haplotypes of the scya8 gene
AU2001286644A1 (en) Haplotypes of the gng7 gene
AU2001273117A1 (en) Haplotypes of the appbp1 gene
AU2002227177A1 (en) Haplotypes of the scya21 gene
AU2001274995A1 (en) Haplotypes of the rlbp1 gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase